CTRI/2022/02/040379尚未招募3 期
An Open label, Clinical Study to Evaluate the Oral Mucosal Safety & Efficacy of HDNT-072012 in Healthy Adult Subjects
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects with age group 18 years to 60 years in general good health and oral health.
- •2.Subjects willing to provide consent to the study
- •3.Subjects with moderate oral hygiene and adhering to basic habits like using standard toothbrush and toothpaste
- •4.No history of any clinically significant medical condition
- •5.No recent history (past 3 months) of overall oral/gum bleeding disorders
- •6.No history of any medical problems requiring hospital care.
- •7.Willing to abide by and comply with the study protocol.
- •8.Available to comply the study procedure for the entire duration of the study.
- •9.Should not have participated in a similar clinical study in the past four weeks and who are willing not to participate in any other clinical study during participation in the current study.
排除标准
- •1.A known history or present condition of hyper sensitivity to any test product.
- •2.No oral substance abuse such as current use or recent history of tobacco, pan, gutka, cigarette
- •3.Pregnant and lactating subjects
- •4.The use of antibiotic, antimicrobial, analgesic medications, desensitizing test product during the previous 1 month.
- •5.Any history of periodontal therapy by surgical interventions.
- •6.Any history of dentine hypersensitivity treatment.
- •7.Any removable device such as a removable partial denture or orthodontic retainer.
- •8.The presence of any large or defective restorations, cracked enamel, or caries on the History hypersensitive tooth.
- •9.Having intrinsic dental stains.
- •10.Having abnormal frenum attachment.
- •11.Having moderate to severe level of calculus and/ tartar.
- •12.Any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of currently using any medication or expects to be on any medication which in the opinion of the investigator, may affect the evaluation of the test product, or place the subject at undue risk.
- •13.Suffering from any form of systemic illness, oral infections, hospitalizations and pharmacological treatment.
研究者
相似试验
尚未招募
2 期
A clinical study to assess safety and effectiveness of toothpaste in healthy adult subjectsCTRI/2022/07/043641Himalaya wellness company
尚未招募
2 期
A Clinical Study to check the Oral Safety & Efficacy of Himalaya Botanique Complete care toothpaste in Healthy Adult SubjectsCTRI/2022/07/043756Himalaya wellness company
尚未招募
2 期
A clinical study to check the safety and effectiveness of toothpasteCTRI/2022/08/044960Himalaya wellness company
尚未招募
2 期
A Clinical Study to check the Oral Safety and Efficacy of toothpaste in Healthy Adult SubjectsCTRI/2022/06/043011Himalaya wellness company
进行中(未招募)
1 期
Study to determine whether adding MLN9708 to the combination of cyclophosphamide and dexamethasone improves the response to therapy in patients who have been newly diagnosed with multiple myeloma and have not received previous anti-myeloma treatmentewly diagnosed multiple myelomaMedDRA version: 14.1Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864EUCTR2013-003113-17-GRMillennium Pharmaceuticals, Inc.70
